The NLRP3 inflammasome is a multi-protein cytoplasmic complex functioning as a pattern recognition receptor that has emerged as a key regulator of sterile inflammation and cell death. Upon activation, NLRP3 assembles a complex comprised of the adaptor protein apoptosis- associated speck-like protein (ASC) and the serine protease caspase-1. This protease cleaves and activates inflammasome target cytokines, mainly IL-1?. Caspase 1 activation can also initiates a distinct form of programmed cell death, called pyroptosis, that allows the release of active NLRP3 inflammasome particles to the extracellular space While focused on the investigation of the specific contribution of NLRP3 inflammasome activation and the downstream mechanisms involved in the development of liver fibrosis, we have made the following key observations: 1) Persistent global NLRP3 inflammasome activation results in spontaneous liver fibrosis; 2) Two important consequences of persistent global NLRP3 activation in the liver include hepatocyte pyroptotic cell death and HSC activation; 3) In murine models and patients with NASH, caspase 1 activity is increased in circulation; and 4) Blocking IL-1 signaling during persistent NLRP3 activation rescues mice from inflammatory changes, but not from HSC activation and fibrosis. These data are remarkable because they identify new molecular pathways of liver fibrosis and provide a window for discovery of novel therapies. Based on these preliminary data we propose the CENTRAL HYPOTHESIS that cell- and time-specific NLRP3 inflammasome activation is a central mechanism that triggers liver fibrogenesis and fibrosis, while pyroptosis and extracellular inflammasomes are key events leading to amplification and perpetuation of NLRP3 inflammasome activity. To investigate this hypothesis our proposal has following SPECIFIC AIMS. FIRST we will establish how NLRP3 inflammasome activation modulates HSC phenotype, fibrogenesis and induces liver fibrosis. SECOND we will determine the role of pyroptosis and extracellular NRLP3 Inflammasome as a mechanism of amplification and perpetuation of inflammasome driven fibrogenesis and liver fibrosis. To address these central issues, we have put together a Multi-PI investigative team including a Pioneered Scientist in Inflammasome Biology, and Experts in Cell Death, Fibrosis and Liver Pathology. The results of these studies will uncover crucial aspects of NLRP3 Inflammasome biology and contribution to liver pathology and may lead to novel therapeutic strategies for treatment of various liver conditions associated with NLRP3 Inflammasome activation.
Growing evidence supports the a key role for NLRP3 inflammasomes, multi-protein cytoplasmic complex that serve as pattern recognition receptors, in various forms of liver diseases including nonalcoholic steatohepatitis (NASH) and alcoholic steatohepatitis (ASH) two of the most common liver disorders in the US for which no effective therapy is available. The results of proposed studies will uncover crucial aspects of NLRP3 Inflammasome biology and its contribution to liver fibrosis that may lead to novel therapeutic strategies and biomarkers to non-invasively monitor inflammasome activity and liver fibrosis.
|Eguchi, Akiko; Feldstein, Ariel E (2018) Extracellular vesicles in non-alcoholic and alcoholic fatty liver diseases. Liver Res 2:30-34|
|Wree, Alexander; Inzaugarat, Maria Eugenia; Feldstein, Ariel E (2018) Transmembrane BAX Inhibitor motif-containing 1, a novel anti-inflammatory approach for nonalcoholic steatohepatitis treatment. Hepatology 67:438-441|
|Hoffman, Hal M; Broderick, Lori (2018) JAK inhibitors in autoinflammation. J Clin Invest 128:2760-2762|
|Mann, Jelena; Reeves, Helen L; Feldstein, Ariel E (2018) Liquid biopsy for liver diseases. Gut 67:2204-2212|
|Inzaugarat, Maria Eugenia; Johnson, Casey D; Holtmann, Theresa Maria et al. (2018) NLRP3 inflammasome activation in hepatic stellate cells induces murine liver fibrosis. Hepatology :|
|Johnson, Jennifer L; Ramadass, Mahalakshmi; Haimovich, Ariela et al. (2017) Increased Neutrophil Secretion Induced by NLRP3 Mutation Links the Inflammasome to Azurophilic Granule Exocytosis. Front Cell Infect Microbiol 7:507|
|Hoffman, Hal M; Broderick, Lori (2017) Editorial: It Just Takes One: Somatic Mosaicism in Autoinflammatory Disease. Arthritis Rheumatol 69:253-256|
|McGeough, Matthew D; Wree, Alexander; Inzaugarat, Maria E et al. (2017) TNF regulates transcription of NLRP3 inflammasome components and inflammatory molecules in cryopyrinopathies. J Clin Invest 127:4488-4497|
|Mridha, Auvro R; Wree, Alexander; Robertson, Avril A B et al. (2017) NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. J Hepatol 66:1037-1046|
|Wree, Alexander; McGeough, Matthew D; Inzaugarat, Maria Eugenia et al. (2017) NLRP3 inflammasome driven liver injury and fibrosis: Roles of IL-17 and TNF in mice. Hepatology :|
Showing the most recent 10 out of 11 publications